References

Polycystic Ovary Syndrome: A Contemporary Clinical Approach

2021 · External reference

Mapping Research Trends of Insulin Resistance in Polycystic Ovary Syndrome From 2017 to 2021: A Bibliometric Analysis

10.3389/fendo.2022.963213 · 2022 · External reference

Novel Antidiabetic Medications in Polycystic Ovary Syndrome

10.15190/d.2022.4 · 2022 · External reference

Recommendations From the 2023 International Evidence‐Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome

10.1093/ejendo/lvad096 · 2023 · External reference

Cangfu Daotan Wan Alleviates Polycystic Ovary Syndrome With Phlegm‐Dampness Syndrome via Disruption of the PKP3/ERCC1/MAPK Axis

10.1186/s13048-023-01200-7 · 2023 · External reference

Effectiveness of Herb‐Partitioned Moxibustion Combined With Electroacupuncture on Polycystic Ovary Syndrome in Patients With Symptom Pattern of Kidney Deficiency and Phlegm‐Dampness

2021 · External reference

Huanglian Wendan Decoction Alleviates Metabolic Syndrome by Reprogramming Macrophage Polarization: Evidence From Multi‐Omics Integration

10.1016/j.phymed.2025.157119 · 2025 · External reference

Network and Experimental Pharmacology to Decode the Action of Wendan Decoction Against Generalized Anxiety Disorder

10.2147/dddt.s367871 · 2022 · External reference

Study on the Mechanism of Huanglian Jiedu Decoction in Treating Dyslipidemia Based on Network Pharmacology

10.1155/2022/2457706 · 2022 · External reference

Identification of the Active Constituents and Significant Pathways of Cangfu Daotan Decoction for the Treatment of PCOS Based on Network Pharmacology

10.1155/2020/4086864 · 2020 · External reference

Effects of TCM on Polycystic Ovary Syndrome and its Cellular Endocrine Mechanism

10.3389/fendo.2023.956772 · 2023 · External reference

Are Dietary and Serum Advanced Glycation End Products (AGEs) Potential Contributors to Inflammation in Women With Polycystic Ovary Syndrome?

10.3390/jcm14165803 · 2025 · External reference

Androgens Increase Accumulation of Advanced Glycation End Products in Granulosa Cells by Activating ER Stress in PCOS

10.1210/endocr/bqaa015 · 2020 · External reference

AGEs‐Related Dysfunctions in PCOS: Evidence From Animal and Clinical Research

10.1530/joe-21-0143 · 2021 · External reference

Contribution of Advanced Glycation End Products to PCOS Key Elements: A Narrative Review

10.3390/nu14173578 · 2022 · External reference

KCa3.1 Channels Mediate the Increase of Cell Migration and Proliferation by Advanced Glycation Endproducts in Cultured Rat Vascular Smooth Muscle Cells

10.1038/labinvest.2012.163 · 2013 · External reference

TCMSP: A Database of Systems Pharmacology for Drug Discovery From Herbal Medicines

10.1186/1758-2946-6-13 · 2014 · External reference

Network Pharmacology: The Next Paradigm in Drug Discovery

10.1038/nchembio.118 · 2008 · External reference

Revised 2003 Consensus on Diagnostic Criteria and Long‐Term Health Risks Related to Polycystic Ovary Syndrome (PCOS)

10.1093/humrep/deh098 · 2004 · External reference

Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction Networks

10.1101/gr.1239303 · 2003 · External reference

The STRING Database in 2017: Quality‐Controlled Protein‐Protein Association Networks, Made Broadly Accessible

10.1093/nar/gkw937 · 2017 · External reference

clusterProfiler 4.0: A Universal Enrichment Tool for Interpreting Omics Data

2021 · External reference

AutoDock Vina: Improving the Speed and Accuracy of Docking With a New Scoring Function, Efficient Optimization, and Multithreading

10.1002/jcc.21334 · 2010 · External reference

UCSF Chimera–A Visualization System for Exploratory Research and Analysis

10.1002/jcc.20084 · 2004 · External reference

Unresolved reference

External reference

Evaluation of Representativeness and Sustainability of PCOS Rat Models Induced by Letrozole With or Without High‐Fat Diet

10.1038/s41598-025-15026-4 · 2025 · External reference

Characteristics of Polycystic Ovary Syndrome Rat Models Induced by Letrozole, Testosterone Propionate and High‐Fat Diets

10.1016/j.rbmo.2024.104296 · 2025 · External reference

Network Pharmacology and Molecular Docking Study on the Treatment of Polycystic Ovary Syndrome With Angelica Sinensis‐Radix Rehmanniae Drug Pair

10.1097/md.0000000000036118 · 2023 · External reference

Study on the Intervention Effect of Qi Gong Wan Prescription on Patients With Phlegm‐Dampness Syndrome of Polycystic Ovary Syndrome Based on Intestinal Flora

10.1155/2020/6389034 · 2020 · External reference

An Experimental Study on the Oxidative Status and Inflammatory Levels of a Rat Model of Polycystic Ovary Syndrome Induced by Letrozole and a New High‐Fat Diet

2024 · External reference

Molecular Mechanism of Modified Huanglian Wendan Decoction in the Treatment of Polycystic Ovary Syndrome

10.1097/md.0000000000033212 · 2023 · External reference

Loureirin B Reduces Insulin Resistance and Chronic Inflammation in a Rat Model of Polycystic Ovary Syndrome by Upregulating GPR120 and Activating the LKB1/AMPK Signaling Pathway

10.3390/ijms252011146 · 2024 · External reference

Multiple Benefits of Empagliflozin in PCOS: Evidence From a Preclinical Rat Model

10.3390/pathophysiology31040041 · 2024 · External reference

Tanshinone IIA Inhibits Ischemia‐Reperfusion‐Induced Inflammation, Ferroptosis and Apoptosis Through Activation of the PI3K/Akt/mTOR Pathway

10.1177/09603271231180864 · 2023 · External reference

Tanshinone IIA Reduces AQP4 Expression and Astrocyte Swelling After OGD/R by Inhibiting the HMGB1/RAGE/NF‐κB/IL‐6 Pro‐Inflammatory Axis

10.1038/s41598-022-17491-7 · 2022 · External reference

TMT‐Based Proteomic and Bioinformatic Analyses of human Granulosa Cells From Obese and Normal‐Weight Female Subjects

10.1186/s12958-021-00760-x · 2021 · External reference

Hesperidin Inhibits Oxidative Stress and Apoptosis of Granulosa Cells in Polycystic Ovarian Syndrome Through the JAK2/STAT3 and PI3K/AKT Pathways

10.1002/ptr.70100 · 2025 · External reference